chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dehydration (Severe); Trembling / Shaky Feeling (Occasional - Moderate); Lethargy (Moderate); Body Ache (Moderate); Trembling / Shaky Feeling (Occasional - Moderate); Light Fever; Nausea (Severe); severe headache; This is a spontaneous report from a contactable consumer. A 29-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Lot Number: EP6955), via an unspecified route of administration on 08Apr2021 at 12:00 PM (at the age of 29-year-old) as single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Lot Number: EP6955), via an unspecified route of administration on 17Mar2021 at 1:00 PM as single dose for COVID-19 immunization. There was no list of any other medications the patient received within 2 weeks of vaccination.The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination.There were no known allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 08Apr2021 at 10:00 AM, the patient experienced moderate lethargy, moderate body ache, severe nausea, severe dehydration, occasional - moderate trembling / shaky feeling, light fever and severe headache. The events were considered serious due to medically significant. The patient was admitted to emergency room and Intravenous treatment was administered for the events. The outcome of events was not recovered.  No follow-up attempts are needed. No further information is expected.
HEADACHE; FEVER; WEAKNESS; SORE ARM; CHILLS; BODY ACHES; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 09-MAR-2021 for prophylactic vaccination. Unable to follow the reporter hence batch number could not be requested. No concomitant medications were reported. On an unspecified date, the subject experienced headache, fever, weakness, sore arm, chills, and body aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache, fever, weakness, sore arm, chills, and body aches. This report was non-serious.
Arm pain and not just slight I can?t sleep I can t sit it is pass tolerable.  My finger are burning and tingling.  It feels Like I have been beat with a baseball bat from the injection site to my wrist and then my fingers are tingling and cold.  Also I have been extremely nauseous since day one.  Have not been eating much.  I just eat enough to take Advil for the pain .  I?m miserable.
Patient reported she had been feeling anxious about receiving the vaccine all day due to its newness.  About 10 minutes after receiving the vaccination she reported an elevated heart rate per her watch. Her hands were shaking mildly.  She denied chest pain, shortness of breath and/or dizziness.  Palpated radial pulse was 130s-140's. BP was 150's/70's.  She was taken to hospital emergency room; she declined any medications. Through  use of meditation techniques and calming practices, her heart rate lowered to 90's, then returned to 120's then lowered again to normal heart rate.
about 10 to 12 patients received expired doses; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (about 10 to 12 patients received expired doses) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (about 10 to 12 patients received expired doses). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (about 10 to 12 patients received expired doses) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment information were reported by the reporter
10/1/21, I received my Covid Booster. I had a headache with chills, body aches and fatigue, just as I had for the first two covid vaccines, which lasted two days. Following the booster a lymph node in my armpit grew to the size of a baseball and lasted a week. On Christmas Eve, I didn?t feel good, so I covid tested and was negative. I had chills, a fever and loss of appetite. From 12/26-1/12 I had 6 sets of fever/chills a day with fevers in the 102-103 degree range. Assuming it was covid, I took 2 more at home COVID tests every couple days, which were negative.12/29 I went to my pcp for a pcr covid test. It was negative. 12/31 I went to Facility to see if maybe I had a UTI. Nothing ever hurt. I was diagnosed with a kidney infection and they took a single blood culture. I was given a shot of antibiotics and a prescription of antibiotics.On the second, hospital, related to Facility, called regarding my blood culture and directed me to the ER. They believed I had a staph infection or sepsis in my blood. They did a sonogram of my kidneys, liver and gallbladder. They admitted me.Once admitted, I had several CT scans, an MRI, all sorts of blood tests to find a unicorn of a virus or bacteria in my blood, a spinal tap and finally a bone marrow biopsy. The worst of all being the covid testing. All the while my miserable fevers/chills continued. It turned out I may never have had a kidney infection and the blood infection was likely a contaminate. Dr., a hematology oncologist diagnosed me with a very rare disease called HLH from markers in my blood, results of the bone marrow biopsy and my enlarged liver and spleen. It was not suspected to be the genetic variety. She and her local colleagues have only seen 3 cases of HLH. I was started on steroids and my fevers stopped. On 1/13 a bed became available at Hospital and I was transferred by non-emergent ambulance. Hospital continued with testing. I had a full body PET scan with contrast to try to find the source of my infection or HLH.They biopsied some skin that got a rash and is itchy and surgically removed lymph nodes in my groin in hopes of finding the cancer they suspect is causing the HLH. Without a source of the HLH they cannot cure me or target my treatment. Nothing showed up on any of the tests or biopsies. Next they biopsied my liver and did another bone marrow biopsy, but again the tests did not provide any cause for the HLH. I was discharged 1/31 with medication to treat the HLH. I developed a seroma where the lymph nodes were removed. On 2/13 I was back at Hospital with a fever of 101 and pain in my leg/groin area. They removed the fluid from the seroma and found staph infection. The results of my covid antibodies test showed I had a high number, so my doctor feared I may have active covid. My home covid test was negative, but I am awaiting the results of the pcr test. I continue to believe the cause of my HLH to be the covid booster.
Pt states he received a smallpox vaccination prior to his symptoms, but I cannot find specific data to this effect.  Pt presented to the ED c/o chest pain and dyspnea on exertion, worsening over 3 days.
Received flu vaccine 11/21/2016, began having fever, aches, chills, severe nausea and vomiting in the evening. Still has some of these symptoms in the morning of 11/22/2016.
p/vax & pt watching brother recv vax & bleed pt fainted about 5 to 10min later;pt had fast uneventful recovery;
This spontaneous report as received from a registered nurse refers to unspecified number of patients of unknown age and gender. The patients' relevant medical history and concomitant medications were not reported. The patient were administered improperly stored doses of (Oka/Merck) VARIVAX (dose, route, lot# and expiration date were not reported) on 06-JAN-2015, 12-JAN-2015, 23-JAN-2015, 26-JAN-2015, 28-JAN-2015, 29-JAN-2015, 30-JAN-2015, 03-FEB-2015, 04-FEB-2015, 05-FEB-2015, 06-FEB-2015, 03-MAR-2015, 06-MAR-2015, 11-MAR-2015, 20-MAR-2015, 25-MAR-2015, 09-APR-2015, 16-APR-2015, 17-APR-2015 and on 22-APR-2015. No adverse effects were reported. No PQC (product quality complaint) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Onset: Tightness in chest/congestion lower bronchii, burning, scratchy eyes. By 6:00PM:  Elevated temperature (101.2 from personal base of 97.5)/severe chills/inflammed eyes. 12/08: Fever gone. Only scratchy throat. No previous flu vacc reactions.
I Woke Up & Noticed I Had A Blister On My Lip, It Was Spread To My Upper Inside Of My Mouth & Gum line & My Nose. It Was Very Painful So I Took My Valtrex & Was Told To Take My Valtrex Daily Instead Of Once Weekly. I Was Still In Pain But Eventually Went Away.
Patient complained of itching-9:06am 11/7/06; 11/7/06 9:28am client complained of shortness of breath to co-workers. First alert team notified and responded. At 9:06am given by mouth Benadryl 25mg given.  At 9:28am Benadryl 50mg IM left arm: Epi 0.5cc SQ Right arm given. Transported via stretcher to ER.
Patient said a rash appeared on her upper left back (adjacent to the vaccination site; sized about 4x6in) and a smaller patch developed in her left lower lumbar region. Rash was described as pin-point and red. Patient's dermatologist referred her to pharmacy. Patient stated using Eucerin which relieved the rash a little but isn't totally gone. Patient was advised to take Benadryl and use hydrocortisone cream and to call the pharmacy and her dermatologist if rash worsened.
Swelling on the left side of face about 45 min. after vaccination. Treatment by physician prednisone 20mg daily x 10 days. BENADRYL 25mg 1 cap. every 12 hours.
Kidney stone 3rd day following  that turned into a UTI Spoke w/ a Physician, who then prescribed antibiotics
Arm soreness after received the Pfizer COVID-19 Vaccines; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old female patient received BNT162b2 (BNT162B2), on 02Apr2021 as dose 1, single (Lot number: ER8733) at the age of 63 years for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 02Apr2021, outcome "recovered" (Apr2021), described as "Arm soreness after received the Pfizer COVID-19 Vaccines".  Additional information: She got the Prevnar 20 vaccine on 27Jan2023, and normally her arm is sore for a little while, which even happened with the COVID vaccines. Other Products was no. Stated that the vaccine was not prescribed by a physician. She is on and they stated that she was eligible for the vaccine. Verified that her arm was sore with all of her Pfizer COVID-19 doses. Stated that if you give her any kind of shot, her arm will hurt. Arm soreness after received the Pfizer COVID-19 Vaccines began the night she received the vaccine and lasted about 2-3 days. Vaccine Administered at Facility. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available) and prior vaccinations (within 4 weeks): If applicable, list any other vaccinations within four weeks prior to the first administration date of the suspect vaccine(s) was none. History was stated that she took vitamins.
Dry, nonproductive cough ,  first day 12/24, fever 105.2 (temporal) 0700 12/25/20.
SEVERE SWELLING FROM DELTOID TO ELBOW, REDNESS, WARMTH
Approx. 3 hours, post vax, child felt hot, face was puffy and had nasal congestion.
Temp of 103.2F with febrile seizure. 2 of brief duration (40-45sec) and 5 minutes between episodes.
No additional adverse events reported.; VARIVAX that had undergone temperature excursion was administered to a patient.; This spontaneous report was received from a nurse regarding a 12-month-old patient of an unspecified gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On 26-SEP-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot #W002601, expiration date: 24-JAN-2024, product quantity 1, (strength, dosage regimen, anatomical location, and route of administration were not provided) administered as prophylaxis (Product storage error).  The improperly stored vaccine underwent a temperature excursion of -11.8 degrees Celsius (C) for 1 hour and 45 minutes without previous excursions (also reported as "with previous temperature excursion", conflicting information). No adverse events were reported.
This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL OVERDOSE (11 patients were given 0.5mL doses as booster doses instead of 0.25 ml) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 ml. On 15-Nov-2021, the patient experienced ACCIDENTAL OVERDOSE (11 patients were given 0.5mL doses as booster doses instead of 0.25 ml). On 15-Nov-2021, ACCIDENTAL OVERDOSE (11 patients were given 0.5mL doses as booster doses instead of 0.25 ml) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was reported. No treatment medications were provided
Case number PHEH2015US019399, is an initial spontaneous report received from a healthcare professional received on 28 Sep 2015. This report refers to an adult male patient of unknown age. Past medical history and concomitant medication were not reported. He was vaccinated Men A lyophilized conjugate component of MENVEO (batch number: A15018 and expiry date: Jan 2016) reconstituted with a diluent from a Zalsrravex instead of Men-CYW-135 liquid conjugate component on an unknown date. No adverse event was reported following this administration error (wrong solution used in drug reconstitution).
Weakness; aching; This case was reported by a consumer via call center representative and described the occurrence of feelings of weakness in a patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   On 27th March 2019, the patient received Boostrix. In March 2019, less than a week after receiving Boostrix, the patient experienced feelings of weakness and general body pain. On an unknown date, the outcome of the feelings of weakness and general body pain were unknown.   It was unknown if the reporter considered the feelings of weakness and general body pain to be related to Boostrix.  Additional details were provided as follows: The patient received booster dose of Boostrix vaccine. The patient was not willing to provide mailling address. The patient provide only contact details to reporter. Follow up could not be pursued.
pt recv vax;pt cried for 5 hr;T 104 p/ apap;PC to MD who instructed to give max apap;took 30 mins later,woke up crying;mom stated not want to nurse;17may95 stated had good noc & seems to be doing fine;
Slight soreness; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Slight soreness) and CHILLS (Chills) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced PAIN (Slight soreness) and CHILLS (Chills). At the time of the report, PAIN (Slight soreness) and CHILLS (Chills) outcome was unknown.      No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-017462 (Patient Link).
Injection given Saturday morning 11-2-02, Monday night started vomiting, fever, aches, diarrhea, chills. In bed 5 days. Called doctor, called in prescription.
Patient complained of soreness and a red rash in the left arm. He also stated that his arm felt hot to the touch. He took Aleve OTC to relieve pain and a dose or two of Benadryl although he denies that he experienced any itching.  He states that the discomfort wasn't significant enough to seek medical treatment.
severe itching and a red rash across a large area in my mid back area; severe itching and a red rash across a large area in my mid back area; This is a spontaneous report from a non-contactable consumer (patient). This 68-year-old female patient received dose 2 of BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE; lot number El9265) via an unspecified route on 05Feb2021 at 11:30 (at the age of 68-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history was not reported. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. Concomitant medications were not reported. The patient previously received dose 1 of BNT162B2 (lot number EL1283) on 15Jan2021 at 19:15 in the left arm for COVID-19 immunization. The patient previously received sulfa drugs from an unknown date for an unknown indication and experienced allergy. On 12Feb2021, the patient experienced severe itching and a red rash across a large area in her mid back area. The patient did not receive any treatment for the events. The outcome of severe itching and red rash across a large area in her mid back area was not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
The Hepatitis B Vaccine with the Pediarix would have been 2nd Dose and I believe should be okay.  The child was seen for a Well Child Visit and should have been seen for a 2 week old well child since he was 3 weeks and 5 days at the time of the visit however the Receptionists and Nurse had him scheduled for the 2 month Well Child so the vaccines were given at this visit.  This was recently discovered by another Provider at the child's 9 month well child visit.  The child did NOT experience any ill effects from the vaccine or Mom did not report any.  My question is should the child be vaccinated since they were not at least 6 weeks old when received the first set of vaccine.
woke up at 2am with mild fever.  had mild fever on and off for about 36 hours.  slept more than usual.  started with runny nose, irratated throat, as coughing on and off. on 8th day after shot, had a lesion on leg where chicken pox vaccine was given.  day 12 took to doctor as a pox had appeared on the lession.  doc confirmed pox and lesion on site where chicken pox shot was given.  day 13 started another temp of about 100.
had a lot of pain in the injection site; had trouble moving arm for 2 days.; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 19Mar2021 at 15:15 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient had no known allergies. Concomitant medications included lisdexamfetamine mesilate (VYVANSE), vortioxetine hydrobromide (TRINTELLIX, brexpiprazole (REXULTI) and cetirizine (MANUFACTURER UNKNOWN), all taken for unspecified indications from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021 at 21:00, the patient had a lot of pain in the injection site and had trouble moving the arm for 2 days. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events trouble moving the arm was resolved on 21Mar2021 and lot of pain in the injection site was resolved on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
SWOLLEN AND TENDER ON LEFT ARM. PATIENT WAS SEEN BY HOSPITAL ER ON 08/22/2007 FOR REACTION TO VACCINES ON LEFT ARM GIVEN ON 08/21/2007.PT WAS TREATED W/KEFLEX. ON 08/23/2007 PT WAS SEEN BY MEDICAL CLINIC F/U VACCINES REACTION STILL SOME SWELLING AND CELLULITIS ON LEFT ARM SITE ON INJECTIONS. RECOMMANED APPY ICE ON AFFECTED AREA AND CONTINUE ON KEFLEX PRESCRIBE BY ER. F/U W/DR IN 1WK.
received Moderna vaccine for second dose instead of Pfizer vaccine; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-Apr-2021 and was forwarded to Moderna on 20-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received Moderna vaccine for second dose instead of Pfizer vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 09-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received Moderna vaccine for second dose instead of Pfizer vaccine). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received Moderna vaccine for second dose instead of Pfizer vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Severe dissociative event (psychotic break) beginning <72hr after administration of vaccine, and continuing another 48 hours before resolution.  Patient has no prior adverse psychiatric history.  Transported to local ER on Monday 11th upon worsening of condition.  Administered Haldol in the ER as a sedative after becoming combative during dissociative state.  Patient woke up Tuesday the 12th with recurrent, but significantly diminished, dissociation, which had largely resolved by late Tuesday.  Patient transported to Mental Health on a 5150. Released Friday the 15th around noon. No recurrent symptoms since.